| 1 |
Chandrasoma P, Wickramasinghe K, Ma Y, et al.Adenocarcinomas of the distal esophagus and " gastric cardia" are predominantly esophageal carcinomas[J]. Am J Surg Pathol, 2007, 31(4): 569-575.
|
| 2 |
Wang CY, Hsu HK, Chang HC, et al.Reflux esophagitis after proximal subtotal gastrectomy[J]. Zhonghua Yi Xue Za Zhi(Taipei), 1997, 59(6): 348-353.
|
| 3 |
Hampel H, Abraham NS, El-Serag HB, et al.Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications[J]. Ann Intern Med, 2005, 143(3): 199-211.
|
| 4 |
Dunbar KB, Souza RF, Spechler SJ, et al.The Effect of Proton Pump Inhibitors on Barrett′s Esophagus[J]. Gastroenterol Clin North Am, 2015, 44(2): 415-424.
|
| 5 |
Jung DH, Yun GW, Lee YJ, et al.Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia In Korean Patients[J]. Gut Liver, 2016, 10(1): 37-41.
|
| 6 |
Zhou Y, Wu XD, Shi Q, et al.Coexistence of gastrointestinal stromal tumor, esophageal and gastric cardia carcinomas[J]. World J Gastroenterol, 2013, 19(12): 2005-2008.
|
| 7 |
Dvorak K, Fass R, Dekel R, et al.Esophageal acid exposure at pH<or＝2 is more common in Barrett′s esophagus patients and is associated with oxidative stress[J]. Dis Esophagus, 2006, 19(5): 366-372.
|
| 8 |
Ichikawa H, Sugimoto M, Sugimoto K, et al.Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis[J]. J Gastroenterol Hepatol, 2015.
|
| 9 |
Pauwels A, Altan E, Tack J, et al.The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease[J]. Neurogastroenterol Motil, 2014, 26(4): 581-588.
|